C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2006
12/26/2006	US7153934 T cell costimulatory polypeptides containing alternative domains
12/26/2006	US7153932 Immunotoxins comprising ribosome-inactivating proteins
12/26/2006	US7153819 Stabilization of antibodies or fragments thereof
12/26/2006	US7153701 Mixing the Fab' antibody having a uniform isoelectric point with analytical sample containing antigen to obtain a mixture comprising immune complex, separating the mixture by performing electrophoresis in a carrier, irradiating an excitation light which excites fluorescent dye, detecting fluorescece
12/26/2006	US7153686 Compositions of enriched central nervous system stem cell and progenitor cell populations
12/26/2006	US7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof
12/26/2006	US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
12/26/2006	US7153667 Discrete acyltransferases associated with type I polyketide synthases and methods of use
12/26/2006	US7153662 Inflammation-specific peptides and the uses thereof
12/26/2006	US7153661 Artificial antibody polypeptides
12/26/2006	US7153510 Recombinant vesiculoviruses and their uses
12/26/2006	US7153508 Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4
12/26/2006	US7153507 A human monoclonal antibody specifically binds to human IL-15 and to inhibit IL-15-induced proinflammatory effects; tumor necrosis factor; antiinflammatory, -arthritic, -carcinogenic, proliferative agents; rheumatic diseases; transplants
12/26/2006	US7153506 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family
12/21/2006	WO2006135793A2 Protein engineering with analogous contact environments
12/21/2006	WO2006135263A1 Fibroblast growth factor receptor-5 antibodies and methods for their use
12/21/2006	WO2006134368A1 Idiotype vaccination with bispecific and multispecific immunoglobulin molecules
12/21/2006	WO2006133560A1 Psp94 diagnostic reagents and assays
12/21/2006	WO2006133486A1 CRYSTAL STRUCTURES AND MODELS FOR Fc RECEPTOR:Fc COMPLEXES AND USES THEREOF
12/21/2006	WO2006119264A3 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer
12/21/2006	WO2006116001A3 Antibodies for the treatment of cancers
12/21/2006	WO2006113347A3 Diagnostic and therapeutic potential of immune globulin intravenous (igiv) products
12/21/2006	WO2006109045A3 Cathepsin s antibody
12/21/2006	WO2006100430A3 Polypeptides
12/21/2006	WO2006096461A3 Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent
12/21/2006	WO2006095180A3 Humananized monoclonal antibodies against sars - associated coronavirus and treatment of patients with sars
12/21/2006	WO2006089133A3 Anti-cd19 antibodies and uses in oncology
12/21/2006	WO2006087533A3 Ricin-binding peptides and methods for use thereof
12/21/2006	WO2006083289A3 Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity
12/21/2006	WO2006073447A3 Enriched pag-55 fraction and methods for early detection of pregnancy in ungulate animals
12/21/2006	WO2006047350A3 IgG IMMUNOGLOBULIN VARIANTS WITH OPTIMIZED EFFECTOR FUNCTION
12/21/2006	WO2006014999A3 Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease
12/21/2006	WO2005100584A3 Production of galactosylated glycoproteins in lower eukaryotes
12/21/2006	WO2005100399A3 Dr5 antibodies and uses thereof
12/21/2006	WO2005095453B1 Specific binding members against synaptophysin
12/21/2006	WO2005062967A3 Novel anti-il 13 antibodies and uses thereof
12/21/2006	WO2005018535A3 Compositions and methods for treatment of severe acute respiratory syndrome (sars)
12/21/2006	WO2005016127A3 Prion-specific peptide reagents
12/21/2006	WO2004101750A3 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
12/21/2006	WO2004069184A3 Methods for treating, preventing and detecting helicobacter infection
12/21/2006	WO2004041172A3 Interferon antagonists useful for the treatment of interferon related diseases
12/21/2006	WO2003054144A3 Human ras interacting protein
12/21/2006	US20060288434 Inhibiting angiogenesis in a mammal by administering an antibody which specifically binds to EphriniB2 or EphB4; cardiovascular disorders
12/21/2006	US20060288431 Marker for undifferentiated state of cell and composition and method for separation and preparation of stem cells
12/21/2006	US20060287513 Compositions and methods for the therapy and diagnosis of breast cancer
12/21/2006	US20060287509 isolated nucleic acid encoding a human antibody that specifically binds to C-ERBB-2 protein product of HER2/NEU oncogene; for diagnosis of cancer/tumors which over express this gene; for immunotoxins and other antitumor/anticarcinogenic agents; less immunogenic
12/21/2006	US20060287508 Methods for stabilizing proteins
12/21/2006	US20060287507 Mammalian cytokine-like polypeptide-10
12/21/2006	US20060287506 Method for separating and concentrating biological materials using continuous-flow ultracentrifugation
12/21/2006	US20060287502 C3b/C4b complement receptor-like molecules and uses thereof
12/21/2006	US20060287501 Soluble truncated polypeptides of the nogo-a protein
12/21/2006	US20060287230 Compositions which can be used for regulating the activity of parkin
12/21/2006	US20060287226 Characterization of a membrane estrogen receptor
12/21/2006	US20060287223 Remodeling and glycoconjugation of peptides
12/21/2006	US20060286671 Efficient generation of expression cell lines through the use of scorable homeostatic reporter genes
12/21/2006	US20060286670 Transplant acceptance inducing cells of monocytic origin and their preparation and use
12/21/2006	US20060286634 Vector
12/21/2006	US20060286612 Spore specific antibodies
12/21/2006	US20060286611 Antibodies against biotinylated histones and related proteins and assays related thereto
12/21/2006	US20060286609 Rabbit monoclonal antibody against Id1 protein
12/21/2006	US20060286595 Independent of the patient's human papilloma virus (HPV) infection status by detecting biomarker(s) selectively overexpressed in high-grade cervical disease; kits
12/21/2006	US20060286593 Transforming Growth Factor Alpha HI
12/21/2006	US20060286592 Increased ability to convert 5-fluorocytosine prodrug to its toxic form
12/21/2006	US20060286584 Compositions and methods for the regulation of cell proliferation and apoptosis
12/21/2006	US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006	US20060286115 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule
12/21/2006	US20060286113 single domain antibody AFAI; binds to non-small cell lung carcinoma; kits
12/21/2006	US20060286112 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
12/21/2006	US20060286111 Tumor necrosis factor related ligand
12/21/2006	US20060286110 Bax-responsive genes for drug target identification in yeast and fungi
12/21/2006	US20060286107 Parathyroid hormone antibodies and related methods
12/21/2006	US20060286104 Superagonistic anti-CD28 antibodies
12/21/2006	US20060286102 Cell surface receptor isoforms and methods of identifying and using the same
12/21/2006	US20060286101 Administering an anti-CD23 antibody and cyclophosphamide; B cell chronic lymphocytic leukemia
12/21/2006	US20060286100 Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
12/21/2006	US20060286099 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006	US20060286098 Derived from cocaine linked to cholera B toxin; antibodies; for treatment of cocaine addiction; immunization
12/21/2006	US20060286097 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006	US20060286096 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006	US20060286095 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006	US20060286094 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/21/2006	US20060286091 RelA-ASSOCIATED INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF
12/21/2006	US20060286085 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
12/21/2006	US20060286066 Pegylated immunoglobulin variable region polypeptides
12/21/2006	US20060286031 Modulators of tissue regeneration
12/21/2006	US20060286030 an antigen binding fragment comprising a heavy chain and a light chain variable region amino acid sequences, associated to effector cells for triggering antibody-dependent cell-mediated cytotoxicity (ADCC) mechanisms; useful for inhibiting proliferation and/or killing melanoma cells
12/21/2006	CA2611048A1 Psp94 diagnostic reagents and assays
12/21/2006	CA2611023A1 Use of panton-valentine leukocidin for treating and preventing staphylococcus infections
12/20/2006	EP1734366A2 New method for the detection of acid-resistant micro-organisms in stool
12/20/2006	EP1734133A2 Heparanase specific molecular probes and their use in research and medical applications
12/20/2006	EP1734126A2 Regeneration
12/20/2006	EP1734124A1 Prostate specific antigen peptides and uses thereof
12/20/2006	EP1734122A2 APO-2 ligand
12/20/2006	EP1734054A2 Anti-human thymidylate synthase monoclonal antibody and hybridoma capable of producing the same
12/20/2006	EP1734053A2 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
12/20/2006	EP1734051A2 Composition and methods for the diagnosis of tumours
12/20/2006	EP1734050A2 Immunization of dairy cattle with GapC protein against streptococcus infection
12/20/2006	EP1734049A1 Tumour-associated peptides that bind to MHC-molecules
12/20/2006	EP1734048A1 Tumor-associated peptides that bind to MHC-molecules
12/20/2006	EP1733743A1 Preventives/remedies for cancer

1 ... 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 ... 1494